MCDADE MARK 4
4 · Tourmaline Bio, Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
MCDADE MARK
Director
Transactions
- Purchase
Common Stock
2024-01-29$32.50/sh+100,000$3,250,000→ 448,431 total(indirect: By Qiming U.S. Healthcare Fund III,L.P.)
Holdings
- 183,177(indirect: By Qiming U.S. Healthcare Fund I,L.P.)
Common Stock
- 110,083(indirect: By Qiming U.S. Healthcare Fund II,L.P.)
Common Stock
- 518
Common Stock
Footnotes (3)
- [F1]The securities are directly held by Qiming U.S. Healthcare Fund III, L.P. ("Qiming III"). Qiming U.S. Healthcare GP III, LLC ("Qiming GP III") is the sole general partner of Qiming III. The Reporting Person is a managing member of Qiming GP III and may be deemed to share voting and dispositive power over the securities held by Qiming III. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
- [F2]The securities are directly held by Qiming U.S. Healthcare Fund I, L.P. ("Qiming"). Qiming U.S. Healthcare GP I, LLC ("Qiming GP") is the sole general partner of Qiming. The Reporting Person is a managing member of Qiming GP and may be deemed to share voting and dispositive power over the securities held by Qiming. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
- [F3]The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming II"). Qiming U.S. Healthcare GP II, LLC ("Qiming GP II") is the sole general partner of Qiming II. The Reporting Person is a managing member of Qiming GP II and may be deemed to share voting and dispositive power over the securities held by Qiming II. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.